Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short vs Long Duration Albendazole in Neurocysticercosis
NCT02243644Phase 3Completed
- Sponsor
- AIIMS New Delhi
- Start
- Mar 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of albendazole in neurocysticercosis (NCC), sponsored by AIIMS New Delhi. Started Mar 2014; status: completed.
02
Drugs
albendazole
03
Conditions
neurocysticercosis (NCC)
Beyond the preview
Go deeper on NCT02243644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02243644.